GH and IGFs

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 95 | ESPE2022 | Next issue

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sept 2022 - 17 Sept 2022

The 60th ESPE Annual Meeting will now be taking place in Rome, Italy.

Free Communications

Previous section
Pituitary, Neuroendocrinology and Puberty

Table of contents

Next section
Late Breaking

hrp0095fc10.1 | GH and IGFs

Growth hormone and childhood-onset craniopharyngioma: When to initiate growth hormone replacement therapy?

hrp0095fc10.2 | GH and IGFs

The first-year growth response to once-weekly growth hormone (GH) treatment can be predicted from the pre-treatment blood transcriptome in children with GH deficiency (GHD)

hrp0095fc10.3 | GH and IGFs

Near final height in 62 twin pairs with twin-to-twin transfusion syndrome is not associated with the GHRd3 genotype

hrp0095fc10.4 | GH and IGFs

Cerebral white matter hyperintensities in young adults born small for gestational age treated with growth hormone during childhood in comparison with untreated controls

hrp0095fc10.5 | GH and IGFs

Features and outcomes of syndromic vs non-syndromic children born small for gestational age (SGA) under growth hormone therapy in a Belgian cohort

hrp0095fc10.6 | GH and IGFs

Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restriction

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts